News

MUSC's pediatric/adult bone marrow transplant program is one of 12 across the U.S. that performed better than expected, according to a new report.

U.S. News and World Report ranks the Pediatric Cardiology & Heart Surgery Program at MUSC Shawn Jenkins Children’s Hospital No. 2 in entire country.

In recognition of Childhood Cancer Awareness Month this September, the inspiring story of Ava, a young leukemia patient, stands out.

An MUSC children’s cancer specialist and other experts from across state find 11% improvement in childhood cancer survival over 25-year period.

The Group 3 subtype of medulloblastoma has the worst prognosis of all the subtypes, but new research is pointing to a potential therapy.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Parents and providers often underestimate the fatigue that pediatric cancer patients are experiencing. An OT student created a coloring book to help.

Symposium will bring together researchers and patient advocates to inform policy and chart the way forward for patients with rare diseases.

A newly approved drug to prevent neuroblastoma relapse is a huge win for patients and their families, says Jacqueline Kraveka, D.O.

Bare minimum reimbursement rates could be a factor in why some clinics may be struggling to offer HPV vaccination in the U.S.